Key facts
- It has raised $3.8M; the latest was PE Growth/Expansion ($3.8M) in Jan 2025.
- Notable investors include Fengate Asset Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for eMAX Health
- ·The full record, as it builds
Funding rounds
No funding rounds for eMAX Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About eMAX Health
Provider of independent research and innovative pharmaceutical commercialization support catering to clients across various segments of the global healthcare system. The company offers independent outcomes monitoring, rebate adjudication, and administrative reporting services, along with effectiveness research, market access strategy and account pull-through programs to optimize the value of biopharmaceutical products, thereby bringing competing interests together to improve health outcomes and lower costs.
- Sector
- Business Products and Services (B2B)
- HQ
- Delray Beach, FL, United States
- Founded
- 2004
- Employees
- 30
- Website
- emaxhealth.net/
- Ownership
- Privately Held (backing)
eMAX Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in eMAX Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on eMAX Health in its N-PORT filings yet. We sweep new filings monthly.